EUCTR2019-001987-31-DE进行中(未招募)1 期
COMBined Active Treatment in Type 2 Diabetes with NASH - COMBAT T2 NASH
Deutsche Diabetes Forschungsgesellschaft e.V.0 个研究点目标入组 192 人开始时间: 2020年6月15日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 192
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Diagnosis of T2D and NASH with fibrosis stage F1-F3
- •- Age between 25 and 75 years
- •- HbA1c = 9.5%
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 100
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 92
排除标准
- •- Contraindications on liver biopsy
- •- Evidence of cirrhosis on liver biopsy
- •- Liver disease of other etiology
- •- History of ketoacidosis
- •- Alcohol consumption >30 g/d for males and >20 g/d for females
- •- Past (=5 years) or current history of alcohol or drug abuse and/or
- •psychiatric disease
- •- Medications that may induce steatosis
- •- Planned pregnancy, pregnant or lactating women, positive pregnancy
- •test, and woman of childbearing potential not using two adequate
- •methods of contraception
研究者
相似试验
已完成
4 期
Combined Active Treatment in Type 2 Diabetes With NASHType 2 DiabetesNon-alcoholic Steatohepatitis (NASH)Non-alcoholic Fatty Liver Disease (NAFLD)NCT04639414German Diabetes Center192
已完成
不适用
Insulin combination therapy in type 2 diabetesDiabetes mellitus type 2 (DM type II)Nutritional, Metabolic, EndocrineDiabetesISRCTN29335793Stichting Julius Research (The Netherlands)200
进行中(未招募)
不适用
Treatment Strategies in Patients with Type 2 Diabetes Mellitus Not Achieving Glycemic Control while on Therapy with Premixed Insulin Analogues and Metformin: A Comparison of Insulin Lispro MM Intensive Mixture Therapy with Progressive Dose-Titration of Insulin Lispro LM or Biphasic Insulin Aspart 30/70 - S019Type 2 Diabetes MellitusEUCTR2006-003076-35-HUEli Lilly and Company Ltd.270
已完成
1 期
Treating To Target in Type 2 diabetesType 2 diabetesNutritional, Metabolic, EndocrineNon-insulin-dependent diabetes mellitusISRCTN51125379ovo Nordisk Limited (UK)700
尚未招募
不适用
A Comparison of Peri-Operative and Post Acute Coronary Syndrome Glycaemic Control in Insulin Requiring Patients with Type 2 Diabetes at St Vincent’s Hospital With and Without Real-Time Continuous Glucose Monitoring.Type 2 diabetes requiring insulinAcute coronary syndromesPost - operative patientsMetabolic and Endocrine - DiabetesCardiovascular - Coronary heart diseaseSurgery - Surgical techniquesACTRN12608000125325St Vincent's Hospital60
